Index of reports
> Cases with Nausea (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Diabeta (Glyburide) where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Diabeta side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-15
Patient: female
Reactions: Oral Discomfort, Product Quality Issue, Nausea, Dizziness
Drug(s) suspected as cause:
Diabeta
Possible Diabeta side effects in 71 year old female
Reported by a consumer/non-health professional from United States on 2011-12-14
Patient: 71 year old female
Reactions: Cholelithiasis, Abdominal Pain, Vomiting, Nausea, Hypoglycaemia, Abdominal Pain Upper
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lantus
Indication: Type 2 Diabetes Mellitus
Glucophage
Dosage: 2000 mg
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Placebo
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2010-08-19
Diabeta
Indication: Type 2 Diabetes Mellitus
Blinded: Saxagliptin
Dosage: last dose 22sep2010
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2010-08-19
End date: 2010-09-22
Other drugs received by patient: Aspirin; Hypertension Medication
Possible Diabeta side effects in 71 year old female
Reported by a consumer/non-health professional from United States on 2011-12-02
Patient: 71 year old female
Reactions: Abdominal Pain, Cholelithiasis, Vomiting, Nausea, Hypoglycaemia, Abdominal Pain Upper
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glucophage
Dosage: 2000 mg
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Blinded: Placebo
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2010-08-19
Lantus
Indication: Type 2 Diabetes Mellitus
Diabeta
Indication: Type 2 Diabetes Mellitus
Blinded: Saxagliptin
Dosage: last dose 22sep2010
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2010-08-19
End date: 2010-09-22
Other drugs received by patient: Aspirin; Hypertension Medication
|